U.S. Markets open in 17 mins
  • Crude Oil

    70.51
    -0.05 (-0.07%)
     
  • Gold

    1,774.30
    -3.90 (-0.22%)
     
  • Silver

    22.53
    -0.04 (-0.17%)
     
  • EUR/USD

    1.1736
    +0.0006 (+0.0469%)
     
  • 10-Yr Bond

    1.3280
    +0.0040 (+0.30%)
     
  • Vix

    22.60
    -3.11 (-12.10%)
     
  • GBP/USD

    1.3635
    -0.0029 (-0.2154%)
     
  • USD/JPY

    109.5400
    +0.3200 (+0.2930%)
     
  • BTC-USD

    44,590.88
    -3,435.44 (-7.15%)
     
  • CMC Crypto 200

    1,058.87
    -4.98 (-0.47%)
     
  • FTSE 100

    7,080.82
    +99.84 (+1.43%)
     
  • Nikkei 225

    29,639.40
    -200.31 (-0.67%)
     

Penumbra, Inc. Schedules Second Quarter 2021 Earnings Release and Conference Call for August 9, 2021

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

ALAMEDA, Calif., July 12, 2021 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the second quarter 2021 after market close on Monday, August 9, 2021 at 4:30 PM Eastern Time. A press release with second quarter 2021 financial results will be issued after market close that day.

Penumbra, Inc. Logo (PRNewsFoto/Penumbra, Inc.)
Penumbra, Inc. Logo (PRNewsFoto/Penumbra, Inc.)

Webcast & Conference Call Information
The conference call can be accessed live over the phone by dialing (833) 350-1434 for domestic and international callers (conference id: 1699031), or the webcast can be accessed on the "Events" section under the "Investors" tab of the Company's website at: www.penumbrainc.com. The webcast will be available on the Company's website for at least two weeks following the completion of the call.

About Penumbra
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra sells its products to hospitals and healthcare providers primarily through its direct sales organization in the United States, most of Europe, Canada and Australia, and through distributors in select international markets. The Penumbra logo is a trademark of Penumbra, Inc. For more information, visit www.penumbrainc.com.

Investor Relations
Penumbra, Inc.
510-995-2461
investors@penumbrainc.com

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-schedules-second-quarter-2021-earnings-release-and-conference-call-for-august-9-2021-301328608.html

SOURCE Penumbra, Inc.